SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " BET " 11,402 found 🔀 AI-powered Shuffle
Xprize founder says 'humans behave better when they’re being watched'
Peter Diamandis is the latest tech executive to argue that global surveillance will make the world a better place, following Larry Ellison's comments in 2024.
Sports books see surge in Missouri World Cup betting
Sports gambling activity is up this month in Missouri with Kansas City hosting six FIFA World Cup matches.
Apple's OLED 'MacBook Ultra' Will Stick With M5 Pro and M5 Max Chips
Apple's upcoming high-end MacBook model featuring an OLED touchscreen display will use the company's current M5 Pro and M5 Max chips, according to Bloomberg's Mark Gurman. The new, top-of-the-line device will launch "between late this year and early next year," Gurman said, adopting the existing high-end Apple silicon chips rather than next-generation M6 versions.
Rangers trade Brett Berard to Canadiens for William Trudeau: Sources
The deal marked the first trade between Rangers team president Chris Drury and his predecessor, the Canadiens' Jeff Gorton.
Chaz Coleman dismissed by Tennessee as Vols' massive transfer bet goes bust
Coleman arrived as a top-10 transfer and one of Tennessee's splashiest NIL-era additions. Months later, the Vols are moving on.
Seattle ups its payout for vandalized small businesses. Is it enough?
For many businesses, the reimbursement "could be the difference between someone making their rent or not, just because this is such a tough time,” said Analog Coffee's owner.
Should I Start A Business From Passion Or With The Intention To Sell?
Sara Blakely did not set out to build a billion-dollar company. She just wanted better underwear.
Gambling disorder diagnoses spike after states legalized sports betting
Researchers analyzed millions of electronic health records and found a major difference between states that greenlit sports gambling and those that didn’t.
Gambling disorder diagnoses spike after states legalized sports betting
Researchers analyzed millions of electronic health records and found a major difference between states that greenlit sports gambling and those that didn’t.
DJ and presenter Trevor Nelson taking a break from work due to health issues
The Radio 2 presenter said he was now "concentrating on getting better".
Paraguay vs Australia Extended Highlights
Check out the full game highlights between Paraguay and Australia in the 2026 FIFA World Cup™. Announced by Mark Scott and Cobi Jones.
Türkiye vs United States Highlights
Check out the full game highlights between Türkiye and United States in the 2026 FIFA World Cup™. Announced by John Strong and Stu Holden.
Paraguay vs Australia Highlights
Check out the full game highlights between Paraguay and Australia in the 2026 FIFA World Cup™. Announced by Mark Scott and Cobi Jones.
Tunisia vs Netherlands Extended Highlights
Check out the full game highlights between Tunisia and Netherlands in the 2026 FIFA World Cup™. Announced by Darren Fletcher and Owen Hargreaves.
Japan vs Sweden Extended Highlights
Check out the full game highlights between Japan and Sweden in the 2026 FIFA World Cup™. Announced by Darren Fletcher and Owen Hargreaves.
Vance dismisses Watergate scandal, says ‘deep state’ went after Nixon
The vice president said he admired Nixon and drew parallels between the past president, who resigned amid pressure in 1974, and Trump today.
Evaluating the robustness and readiness of large frontier models in health AI applications
Nature Medicine - Adversarial evaluation of leading AI models uncovers gaps between benchmark success and robustness, highlighting limitations in current health AI benchmarks and their ability to...
Ecuador vs Germany Extended Highlights
Check out the full game highlights between Ecuador and Germany in the 2026 FIFA World Cup™. Announced by Ian Darke and Landon Donovan.
ESPN believes Detroit Lions have best weapons in NFL
ESPN’s Bill Barnwell believes the Detroit Lions have better offensive weapons than any other NFL team in 2026.
Ecuador vs Germany Highlights
Check out the full game highlights between Ecuador and Germany in the 2026 FIFA World Cup™. Announced by Ian Darke and Landon Donovan.
Neuroimaging utilization in emergency departments has increased year-over-year for a decade
Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments.
Less Islamism, More Nationalism
In Iran and across the Middle East, the bond between religion and politics is getting weaker.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Trump budget request omits funds for L.A. fire relief, prompting criticism from senators
The omission is the latest strain in a yearlong standoff between California leaders and the Trump administration over federal disaster aid.
UToledo Business Camp Hosts Pitch Competition
Dr. Terribeth Gordon-Moore, senior associate dean at the Neff College of Business, discusses the RISE Into Business summer enrichment camp that culminated in teams of high school students pitching their T-shirt business ideas to a panel of judges.
Google Finance finally gets a mobile app as AI-powered overhaul leaves beta
It took 20 years, but the Finance app arrives just in time to be packed full of AI.
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Trump Keeps Undercutting Republicans’ Message, Squandering His Own Trifecta
Divisions between the president and his party on Capitol Hill have muddled Republicans’ midterm pitch to voters, and have crippled the G.O.P. at what should be the peak of its power.
Life Aboard the Langseth: A Q&A With Chief Science Officer Cody Bahlau
On Columbia’s global research vessel, the R/V Marcus G. Langseth, Bahlau serves as the key link between scientists, crewmembers and operations on shore.
This Simple Trick Can Make Your Coffee Taste Way Better, Says Physics
If you love pour-over coffee it could serve you well to change how you pour.
Rogers Computer Science Teacher Named Tops in the State
Instructor and coach, Anthony Hanos with members of the cyber security program, students Brandon Wilson, Kerian Santiago and Alex Bettencourt. The sister sectors of computer science, information technology and cybersecurity, continue to be among the fastest growing industries in the country, according to the U.S. Bureau of Labor Statistics. Luckily, Newport area high schoolers interested
'This is the next jump in technology': World's first sub-1nm chip keeps Moore's Law alive a little longer
IBM's NanoStack architecture has helped scientists cram 100 billion transistors onto a computer chip, delivering 50% better performance and consuming 70% less energy than the current generation.
Living with a cat: the mental health impact scientists are only now discovering - Futura-Sciences
A Surprising Connection Between Cats and Schizophrenia? An Australian study has revealed an unexpected link between cat ownership and the risk of developing schizophrenia. Researchers analyzed 17 studies conducted over 44 years, spanning 11 different countries. Their conclusion? Living with a cat could actually double your risk of developing schizophrenia-related...
LA's political coalitions have been shifting. Nithya Raman will shuffle them even more
As Mayor Karen Bass and challenger Nithya Raman look to attract new supporters, a fault line between older and newer Angelenos could emerge.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Around the MHS
This edition of news from around the Military Health System for the week of June 22-26, 2026, includes a vital partnership between Offutt Air Force Base and the American Red Cross, new Uniformed Services University research on stress fractures, and Naval Medical Research Unit EURAFCENT participates in a multinational readiness exercise.
The Heart-Healthy Way to Lift Weights, Explained by a Doctor
In TODAY.com’s Expert Tip of the Day, a sports medicine doctor reveals whether it’s better to use heavier weights with fewer reps or lighter weights with more reps for a healthy heart.
Political strategist on the growing tensions between Trump and Senate Republicans
NPR's Michel Martin speaks with political strategist Alex Conant about President Trump's tense meeting with Republican senators on Capitol Hill.
CEOs and CIOs Differ Sharply on AI Business Impact and Transformation Success, Protiviti Survey Finds
/PRNewswire/ -- A new Protiviti Global Transformation Survey, The Alignment Advantage in Transformation, finds a significant gap between CEOs and technology...
Elizabeth Warren says ‘frenzy’ of mergers under Trump could be reversed
Senator warns of ‘tsunami of anger’ against big companies and suggests future administrations may undo key deals
Jeffrey Epstein's friends' settlements draw Congress' interest
Members of Congress have discussed issuing subpoenas to find out about the NDAs between some of Jeffrey Epstein's friends and his accusers.
Union issues spark conflict between Group Health Co-op and members
Changes in the Group Health bylaws have become a point of contention for members who say they are ignored by the co-op's management,
Mookie Betts continues resurgent streak with 300th career homer in Dodgers win
Czechia vs Mexico Extended Highlights
Check out the full game highlights between Czechia and Mexico in the 2026 FIFA World Cup™. Announced by Derek Rae and Rob Green.
Betts homers for No. 300, Ohtani dominates after early trouble
MINNEAPOLIS — For a brief moment Wednesday night at Target Field, Shohei Ohtani looked vulnerable.
Sen. Elizabeth Warren: ‘Thank you Donald Trump’ for the issue that will decide the midterms
Sports betting boosts viewership for top-watched World Cup matches, new data shows
World Cup fever is growing, and new viewership data shows some matchups are drawing far more attention than others — with sports betting playing a major role in
Morocco vs Haiti Extended Highlights
Check out the full game highlights between Morocco and Haiti in the 2026 FIFA World Cup™. Announced by JP DellaCamera and Lori Lindsey.
Scotland vs Brazil Extended Highlights
Check out the full game highlights between Scotland vs Brazil in the 2026 FIFA World Cup™. Announced by Ian Darke and Landon Donovan.
Morocco vs Haiti Highlights
Check out the full game highlights between Morocco and Haiti in the 2026 FIFA World Cup™. Announced by JP DellaCamera and Lori Lindsey.
Scotland vs Brazil Highlights
Check out the full game highlights between Scotland and Brazil in the 2026 FIFA World Cup™. Announced by Ian Darke and Landon Donovan.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
Healthcare Providers Look Beyond Price To Deliver Better Value
A new approach to procurement promises to not just produce much-needed cost savings but also improve outcomes for patients.
Apple tells Siri AI to clearly refuse requests to summarize URLs
A new rule added to Siri AI’s system prompt in iOS 27 beta 2 changes how it should handle requests involving extracting or summarizing content behind a URL.
OpenAI triumphs in brutal $26M political fight against Anthropic
Bores quickly became the pawn between the two California AI companies.
Switzerland vs Canada Extended Highlights
Check out the full game highlights between Switzerland and Canada in the 2026 FIFA World Cup™. Announced by Jacqui Oatley and Warren Barton.
Meta's Zuckerberg enters the prediction market arena
Mark Zuckerberg is launching his next major project: a betting platform modeled after Polymarket. The prospects for success are good, alarming experts.
Switzerland vs Canada Highlights
Check out the full game highlights between Switzerland and Canada in the 2026 FIFA World Cup™. Announced by Jacqui Oatley and Warren Barton.
4 Takeaways From Canada's Group-Stage Finale Loss To Switzerland
Both teams advance to the World Cup knockout round, but one clearly looks better than the other.
Google's Gemini 3.5 Pro release slips to July
Google's next big AI model is coming later than promised, but the company is trying to use the extra time to make it better.
Online violence against women in politics: what shapes political party responses to technology-facilitated gender-based violence?
Political parties have a primary role to play in tackling online violence against women and gender diverse politicians. While the prevalence and impact of TFGBV, such as coordinated disinformation campaigns, deepfake image-based sexual abuse or trolling are well documented, many parties are still building their knowledge on how to respond effectively and have not put in place internal practices and policies that respond to the rapidly evolving, poorly regulated digital ecosystem. About the ReportIn order to promote and protect fair and democratic participation in politics, this ALIGN Report explores what political parties are doing in response to TFGBV and what factors shape their action. The findings, based on existing literature and interviews with gender and politics professionals, indicate there are three sets of factors which donors, civil society and practitioners should consider when designing action to support political parties to respond to TFGBV internally. These are: (1) gender norms; (2) socio-political environment; and (3) internal party factors.Key messagesUnequal gender norms are ubiquitous across politics, shaping expectations of leaders to be strong and assertive, and practices of political parties to uphold masculinist values and sustain cultures of silence. These often lead to weak response to TFGBV against women politicians.The socio-political context can incentivise or disincentivise action, depending on the salience of gender issues, which are increasingly weaponised. Electoral competitiveness, domestic laws (i.e. quota requirements), and even the political system or global normative frameworks influence political will to act.Internal party factors that shape responses will vary across countries and contexts, but include: structures to enforce codes of conduct, policies and reporting mechanisms on (TF)GBV, political ideology, extent of centralisation of leadership, and crucially the meaningful participation of women in decision-making positions, not least through internal women’s wings.Party responses can be seen as a spectrum, with actions falling between active discouragement to address TFGBV to commitment to transform unequal norms and practices within the party.About the ToolkitTogether with the report, this ALIGN toolkit offers gender professionals and others working on democratic strengthening a set of guiding questions and reflection prompts to identify which responses could be most effective and suitable in different contexts. These actions can complement other solutions to TFGBV, such as regulations promoting safety by design. The assessment spans a broad range of factors including: (1) different manifestations of gender norms, (2) the socio-political environment and (3) internal party structures.Key messagesPolitical parties are duty-bound to take action internally to respond to the significant threats posed to women members and candidates, including from their own party colleagues, affiliates and political peers.Existing party approaches to TFGBV can be assessed along a spectrum which ranges from active discouragement and passive acceptance to minimal response and transformative change.To generate effective and context-appropriate solutions to TFGBV, it is important to consider how gender norms shape leadership expectations and internal party practices, while also analysing the impact of the socio-political environment. While actions to support women to stay safe online are very common, codes of conduct and measures to strengthen women’s voice and power in the parties are proposed as most transformative solutions.
Julian Edelman's blunt advice for Patriots with Christian Gonzalez
Julian Edelman shared his thoughts on the ongoing contract situation between the Patriots and star cornerback Christian Gonzalez.
Scientists observe water switching between 2 different molecular structures, boosting decades-old theory
For decades, scientists suspected water secretly behaves like two different liquids. A new AI-powered study has finally caught it happening at the molecular level.
New DNA study of Neanderthals bolsters suspicions of human-driven extinction
Analysis of 27 genomes reveals more diverse, better-connected populations and challenges the idea that genetic decline caused their disappearance
'Supergirl' review: Better than the comic, but not DC's best
Milly Alcock and Jason Momoa bring big attitude to James Gunn's relaunched DC Universe.
QED Science Launches AI Infrastructure for Scientific Validation
Recognizes The 1% After Blind Evaluation of 57,455 Scientific PreprintsTEL AVIV, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- QED Science, a science validity engine and modern infrastructure for researchers, funders, institutions and life science organizations today launched The 1%, the top 574 life science preprints. The company anonymously scored 57,455 bioRxiv preprints submitted between May 2025 and April 2026 for originality and validity. The ranking is powered by QED Score, QED Science’s vali
New Office at SBU Links Climate, Community and Health
Stony Brook's new Office of Health Equity and Climate Medicine Research brings together groups to better understand how the environment shapes health outcomes.
Startup’s strategy challenges EV industry assumptions
A new EV startup led by a former Amazon executive is betting that a low-cost, highly customizable pickup starting at just under $25,000 could help it achieve something that has eluded many EV startups: profitability, CNBC reports. The central goal for Slate Auto and CEO Peter Faricy is to make a full-size, practical truck accessible […]
Partnership to Launch $280 Million Mixed-Use Entertainment District Surrounding Neyland Stadium in Knoxville
Knoxville, Tenn. — A public-private partnership between the University of Tennessee and a newly formed development platform comprising Arctos, RVX - Development, Entertainment, Mixed-use, News, Tennessee
What Has Andy Burnham, Britain's Likely Next Prime Minister, Said About Trump?
If Burnham’s planned leadership bid remains unchallenged, he could replace Starmer in a matter of weeks and it will likely fall on him to heal the rift between Washington and Westminster.
Google’s New $100 Speaker Makes a Weak Case for Gemini in the Home
The Google Home Speaker is the first new device of its kind to come from Alphabet Inc. in six years. In that time, Google has reshaped itself as an industry leader in artificial intelligence, with its Gemini platform now ubiquitous across consumer hardware like smartphones and web services like Search, Workspace and YouTube.
An Olympic-sized collaboration between Lake Placid, Big Apple
Commentary: Governor Kathy Hochul’s recent announcement about New York City possibly hosting the Olympics isn’t a new idea.
A preventable tragedy: What my sister’s death taught me about public health
Rabies is 100% preventable when institutions work together. We must engage trusted community leaders and break down siloes between animal and human health.
Young children losing health coverage faster than older kids — but still faring better in California
The latest education news updates from EdSource.
NM lawmaker urges tribes to reopen gaming compact to allow online sports betting
Rep. John Block's comments came as the state and several pueblos are suing online platform Kalshi allegedly allowing illegal sport gambling.
Business bankruptcies down but closures and farm reorgs up
Between 2019 to 2026, 292 businesses in South Dakota filed for bankruptcy.
Apple aims for better and more entertainment offerings, executive Cue says
Apple aims to release "better and more" TV shows and movies on its streaming service and in movie theaters, senior executive Eddy Cue told Reuters as he accepted an entertainment industry honor in France.
How to bet responsibly during the World Cup
With billions of more dollars and dozens of more games, this World Cup will be a bookmaker bonanza. Here's how to keep yourself safe while wagering.
Caitlin Clark's argument with her coach went viral. How did Indy sports reporters handle the story?
To anyone who’s familiar with WNBA coverage, it’s no surprise that a recent video of a mid-game disagreement between Caitlin Clark and her coach went viral.
Mamdani extends influence with clean sweep in N.Y., Trump hedges in South Carolina: The latest primary results
Your complete guide to the most important contests between now and November.
To age better, we need to rethink health itself
Challenging conventional thinking has historically brought new ways to maximize health and improve quality of life while ageing. Here's what's needed now.
Veteran District 39 Sen. Nancy King trails political newcomer Amar Mukunda in primary election
Other Democratic incumbents with challengers appear set to return to Annapolis next year
Diabetes patients in Gaza face survival battle amid war shortages
Insulin and equipment shortages in Gaza pose fatal risks, leading to critical health complications.
Panama vs Croatia Highlights
Check out the full game highlights between Panama and Croatia in the 2026 FIFA World Cup™. Announced by Ian Crocker and Owen Higginbotham.
Wilson wins GOP nomination for South Carolina governor after Trump hedges his bet on race
South Carolina Attorney General Alan Wilson won a runoff election on Tuesday, swiftly routing the candidate initially endorsed by President Donald Trump to be the Republican nominee for governor.
A review argues the family dog may become science’s unlikely ally against autism
This peer-reviewed Perspective synthesizes a decade of research on a surprising candidate for autism science: the laboratory Beagle. Drawing together scattered studies, the review authors argue that dogs carrying engineered changes in the Shank3 gene reproduce core human features of autism spectrum disorder, including social withdrawal, altered sensory responses, and reduced attention to the eyes of a face. The synthesis assembles, for the first time in one place, the parallels between mutant dogs and autistic people, alongside early signals that oxytocin, a psychedelic, and a third compound may soften these traits. The authors frame the dog as a complementary, ethically governed model, not a replacement for existing ones.
Here’s everything new in Android 17 QPR1 Beta 5 [Gallery]
With Android 17 QPR1 Beta 5 today, Google is rolling out a second wave of bug fixes for Pixel devices on the preview...
Gemini Intelligence makes brief Pixel 10 series appearance on Android 17 QPR1 Beta
Google today is rolling out Android 17 QPR1 Beta 5 and it’s mainly just a bug fixer except for the inclusion of the Gemini Intelligence logo.
2026 World Cup Odds: Back Offensive Display In Canada-Switzerland
Will Hill delivers his best bet for Wednesday's pivotal Group B showdown between Canada and Switzerland.
Apple releases new AirPods beta firmware, including first build for AirPods Max 2
Following the release of iOS 27 beta 2, Apple is rolling out the first firmware beta for AirPods Max 2, alongside second beta builds for other supported AirPods models.
Android 17 QPR1 Beta 5 is out now for your Pixel phone to test
We only just got Android 17 stable, but testers are already getting a preview of Android's latest additions with QPR1 Beta 5.
Best Bets: A quick guide to La Jolla entertainment and experiences
Local events and activities
BetMGM, MLB Expand Sports Betting Partnership
The sportsbook will maintain prominent visibility across MLB platforms while expanding fan-facing experiences.
Google Pixel phones get better wireless audio quality in Android 17
While wired audio is certainly trying to make a comeback, wireless earbuds and headphones are more prevalent today than ever...
Prime Day has served up several great deals on 4K TVs
With the quality of TVs from each year getting so close, it’s a better idea to save big on last year’s models.
Portugal vs Uzbekistan Highlights
Check out the full game highlights between Portugal and Uzbekistan in the 2026 FIFA World Cup™. Announced by Darren Fletcher and Owen Hargreaves.
Senate NDAA adds protections for ‘political speech’ by military retirees amid Hegseth-Kelly battle
The Senate’s defense authorization bill includes language that would better protect retired service members who speak out against the government in the midst of a battle between Sen. Mark Kelly (D-…
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
Chrome Autofill rolling out deeper Google Wallet integration
Google is introducing deeper integration between Google Wallet and Chrome Autofill to further streamline the experience of filling out...
9 Fruits With the Most Prebiotics For Better Gut Health
Prebiotics are a type of fiber that feeds the good bacteria in your gut, supporting better digestion and overall health. These fruits are a tasty way to get more prebiotics.